COMMUNIQUÉS West-GlobeNewswire

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
22/07/2024
SARASOTA, FL, July 22, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery [...]
Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders
22/07/2024
TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, [...]
Cytel Unveiled as OneMedNet’s Newest Alliance Partner
22/07/2024
Cytel’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Further to its press release [...]
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
22/07/2024
BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA [...]
Sanofi: Information concerning the total number of voting rights and shares – June 2024
22/07/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Juin 2024
22/07/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
TELA Bio to Announce Second Quarter 2024 Financial Results
22/07/2024
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
22/07/2024
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial [...]
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
22/07/2024
MENLO PARK, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2024. The [...]
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
22/07/2024
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
22/07/2024
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report [...]
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
22/07/2024
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business [...]
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
22/07/2024
WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Clover Health to Report Second Quarter 2024 Financial Results on August 5
22/07/2024
FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great healthcare to [...]
Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock
22/07/2024
$12.9 Million Transaction Includes Approximately $3.4 Million of New Funding and a $9.5 Million Full Cancellation of Outstanding Senior Notes and Extinguishment of Series B Preferred Shares The Company Also Established [...]
Aesthetic Medicine™ Team Launches New Membership Program
22/07/2024
Get Major Savings on Injectables, Laser Treatments, and Other Cosmetic Procedures with a New Mobile App for the Oregon Practice LAKE OSWEGO, Ore., July 22, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medicine™, a premier medical [...]
MEDIROM Healthcare Technologies Announces Business Transfer from Y’s, Inc.
22/07/2024
TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that its subsidiary MEDIROM Rehab Solutions Inc. entered into an agreement to purchase [...]
Plant Advanced Techonolgies : Hausse du Chiffre d’Affaires Combiné au 30 juin 2024
22/07/2024
Vandœuvre-lès-Nancy, le 22 juillet 2024 - 18 : 30 (CET) Communiqué de presse Pour diffusion immédiate Hausse du Chiffre d’Affaires Combiné au 30 juin 2024 Chiffre d’affaires semestriel non audité du Groupe PAT à plus de [...]
Brain Power Wellness Staff Reviews Successes and Strengthens Team Dynamics at Annual Retreat
22/07/2024
Brain Power Wellness held its annual staff retreat, where team members celebrated, reflected, and engaged in team-building activities, emphasizing the importance of reconnection and collective growth QUEENS, N.Y., July [...]

Pages